Evidence map›Paper›PMID 27236213›Full record

ReviewDNA repair2016

DNA damage tolerance by recombination: Molecular pathways and DNA structures.

Dana Branzei, Barnabas Szakal

Open access · hybridAbstract readReview
In one paragraph

Review in DNA repair, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 156 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Genome Sequencing ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  11. RAD52 prevents accumulation ofbioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dana BranzeiIFOM, The FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy. Electronic address: dana.branzei@ifom.eu.
Barnabas SzakalIFOM, The FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
FIRC Institute of Molecular Oncology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Replication perturbations activate DNA damage tolerance (DDT) pathways, which are crucial to promote replication completion and to prevent fork breakage, a leading cause of genome instability. One mode of DDT uses translesion synthesis polymerases, which however can also introduce mutations. The other DDT mode involves recombination-mediated mechanisms, which are generally accurate. DDT occurs prevalently postreplicatively, but in certain situations homologous recombination is needed to restart forks. Fork reversal can function to stabilize stalled forks, but may also promote error-prone outcome when used for fork restart. Recent years have witnessed important advances in our understanding of the mechanisms and DNA structures that mediate recombination-mediated damage-bypass and highlighted principles that regulate DDT pathway choice locally and temporally. In this review we summarize the current knowledge and paradoxes on recombination-mediated DDT pathways and their workings, discuss how the intermediate DNA structures may influence genome integrity, and outline key open questions for future research.

Indexed as

DNA Mismatch RepairRecombinational DNA RepairAnimalsBase Pair MismatchDNADNA Breaks, Double-StrandedDNA-Directed DNA PolymeraseDNA End-Joining RepairDNA HelicasesDNA ReplicationGenomic InstabilityHumansMammalsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsDNADNA-Directed DNA PolymeraseDNA HelicasesSaccharomyces cerevisiae ProteinsChromosome replicationDNA damage toleranceFork reversalHomologous recombinationPCNAReplication stressUbiquitin/SUMO modifications

Identifiers

PMID27236213
PMCPMC4962778
OpenAlexW2394888858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.